Bank of America Corp DE established a new position in Revolution Medicines, Inc. A Form 13F filing with the Securities and Exchange Commission detailed this move.
The SEC reported the filing on September 18, 2026. Bank of America purchased 983,911 shares during the second quarter.
The stake was valued at approximately $184.27 million. This represents about 0.46% of Revolution Medicines.